文献速递先天性心脏病外科

婴儿心脏手术中口服甲状腺素补充:双盲安慰剂对照随机临床试验

Oral thyroxin supplementation in infants undergoing cardiac surgery: A double-blind placebo-controlled randomized clinical trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-06-04

这项前瞻性随机双盲安慰剂对照试验纳入100例接受开放心脏手术的婴儿,比较口服甲状腺素(5 μg/kg)与安慰剂。结果显示甲状腺素组心脏指数更高,复杂先天性心脏病亚组机械通气时间、ICU停留和住院时间更短,治疗干预评分系统评分更低。

要点

  • 甲状腺素组心脏指数在全部时间点均高于安慰剂组(P=.004)。
  • 复杂亚组甲状腺素组机械通气时间3.85±0.93天,短于安慰剂组4.66±1.55天(P=.001)。
  • 复杂亚组甲状腺素组ICU停留6.79±2.26天、住院15.70±4.77天,均短于安慰剂组。

核心结论

  • 口服甲状腺素补充改善心脏指数并减少正性肌力药物需求。
  • 在复杂先天性心脏病婴儿中,口服甲状腺素还缩短机械通气时间、ICU停留和住院时间,并降低治疗干预评分系统评分。

研究设计与样本

  • 前瞻性随机双盲安慰剂对照临床试验,纳入100例接受开放心脏手术的婴儿。
  • 甲状腺素组50例,于术前12小时口服甲状腺素5 μg/kg,此后每日一次至ICU停留结束;安慰剂组50例。
  • 记录术中及术后变量,测量心脏指数、围术期血清甲状腺激素水平及血清白细胞介素-6和肿瘤坏死因子-α。
  • 二次分析将患者分为简单和复杂亚组。

主要发现

  • 主要分析显示甲状腺素组心脏指数高于安慰剂组。
  • 复杂亚组中,甲状腺素组与安慰剂组机械通气时间分别为3.85±0.93天和4.66±1.55天(P=.001)。
  • 复杂亚组中,甲状腺素组与安慰剂组ICU停留分别为6.79±2.26天和8.33±3.09天(P=.03),住院时间分别为15.70±4.77天和18.90±4.48天(P=.01)。
  • 简单亚组中甲状腺素组与安慰剂组无显著差异。
  • 心脏指数在全部时间点甲状腺素组更高(P=.004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Decreases in serum total thyroxin and total triiodothyronine occurs after cardiopulmonary bypass, and is reflected as poor immediate outcome. We studied effects of oral thyroxin supplementation in infants who underwent open-heart surgery. METHODS: In this prospective study, 100 patients were randomized into 2 groups: 50 in the thyroxin group (TH) and 50 in the placebo group (PL). Patients in the TH group received oral thyroxin (5 μg/kg) 12 hours before surgery and once daily for the remainder of their intensive care unit (ICU) stay. Data on intraoperative and postoperative variables were recorded. Cardiac index (CI) was measured. Perioperative serum thyroid hormone levels and serum interleukin-6 and tumor necrosis factor-α were measured. Secondary analysis was performed by dividing patients into simple and complex subcategories. RESULTS: Results of the primary analysis indicated a higher CI in the TH compared with the PL. In the complex category, the mean duration of mechanical ventilation was 3.85 ± 0.93 and 4.66 ± 1.55 days in the TH and PL, respectively (P = .001). Mean ICU stay was 6.79 ± 2.26 and 8.33 ± 3.09 days (P = .03), and mean hospital stay was 15.70 ± 4.77 and 18.90 ± 4.48 days (P = .01) in the TH and PL, respectively. There were no significant differences between the TH and the PL in the simple category. CI was higher in the TH at all time points (P = .004). The average therapeutic intervention scoring system scores for the first 2 days were higher in the PL in the complex category. CONCLUSIONS: Oral thyroxin supplementation improves the CI and reduces the inotropic requirement. In addition, it reduces the duration of mechanical ventilation, ICU and hospital stay, and therapeutic intervention scoring system in infants after surgery for complex congenital heart defects.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Talwar S, Bhoje A, Khadagawat R, et al. Oral thyroxin supplementation in infants undergoing cardiac surgery: A double-blind placebo-controlled randomized clinical trial. J Thorac Cardiovasc Surg. 2018. PMID: 30119284. doi:10.1016/j.jtcvs.2018.05.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。